Prevention of Osteoporosis in Mice after Ovariectomy via Allograft of Microencapsulated Ovarian Cells
Authors:
Open Access
- 25 January 2010
- journal article
- research article
- Published by Wiley in The Anatomical Record
- Vol. 293 (2) , 200-207
Abstract
It is believed that estrogen deficiency is one of the major risk factors associated with osteoporosis. To investigate the effects of the transplantation of microencapsulated ovarian cells in estrogen‐deficient mice, ovarian cells from female Kunming (KM) mice (6‐weeks old) were separated, cultured, and microencapsulated with alginic acid‐polylysine‐alginic acid. Female KM mice (8‐weeks old) were randomly separated into three groups: intact (normal), ovariectomized (OVX), and treatment (OVX+ implantation). Microencapsulated ovarian cells were found to secrete estrogen at normal levels in vitro. Ninety days after transplantation, serum estradiol levels in the OVX group were significantly lower, and the trabecular bone amount and volume were decreased when compared with the normal group. The expression of alkaline phosphatase in chondrocytes appeared lower, while the expression of matrix metalloproteinase 9 (MMP‐9) in the bone matrix was higher. The ratio of MMP‐9‐positive chondrocytes and osteoblasts to osteoclasts was significantly lower than that of the normal group. The concentrations of hydroxyproline (Hyp), Ca, and P in the left femurs of the OVX group were lower than those of the normal group. However, the aforementioned changes were not seen in the treatment group. In conclusion, microencapsulated ovarian cells survive well after transplantation and secrete estrogen in vivo, and they can prevent in some degree osteoporosis caused by ovariectomy. Anat Rec, 2010.Keywords
This publication has 16 references indexed in Scilit:
- Prevention of Osteoporosis and Hypogonadism by Allogeneic Ovarian Transplantation in Conjunction With Intra-Bone Marrow–Bone Marrow TransplantationTransplantation, 2007
- How to evaluate the risk-benefit ratio of the low-dose hormone replacement therapy?The Journal of Steroid Biochemistry and Molecular Biology, 2006
- Osteoporosis prevention and therapy: preserving and building strength through bone qualityOsteoporosis International, 2006
- Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapyProstate Cancer and Prostatic Diseases, 2005
- Postmenopausal hormone therapy: from monkey glands to transdermal patchesJournal of Endocrinology, 2005
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Generation of Alginate-Poly-L-Lysine-Alginate (APA) Biomicrocapsules: the Relationship Between the Membrane Strength and the Reaction ConditionsArtificial Cells, Blood Substitutes, and Biotechnology, 1994
- Failure mechanisms in human vertebral cancellous boneBone, 1994
- Encapsulation of Rat Islets of Langerhans Prolongs Xenograft Survival in Diabetic MiceDiabetes, 1986
- Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis.Journal of Clinical Investigation, 1981